vTv Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -42.0% | -47.1% | -25.7% | +10.7% | -82.1% | +141.0% | -5.3% | +3.4% | -2.2% | -1.1% | -82.0% | |
| – | – | +207.5% | +38.0% | -26.6% | -43.3% | -33.5% | +133.5% | -46.0% | +24.1% | +74.7% | +36.9% | |
| – | -1,079.6% | – | – | – | -53.8% | -18.0% | -738.8% | – | – | – | – | |
| – | – | +100.2% | +23.3% | -249.8% | – | – | – | +15,285.7% | -18.4% | -223.8% | – | |
| – | +215.2% | -16.3% | -34.5% | -91.2% | +1,300.0% | -70.0% | +0.0% | +0.0% | -100.0% | – | – | |
| – | -149.1% | +5.1% | -69.9% | – | +3,357.1% | -108.7% | +0.0% | +0.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -99.1% | -67.3% | +7,019.2% | -95.4% | +1,354.2% | – | – | – | – | – | |
| – | -42.5% | -35.1% | -39.8% | -165.2% | +106.1% | -50.8% | – | -118.6% | +3.1% | +478.8% | -100.0% | |
| – | +300.0% | -90.5% | -36.4% | +121.5% | +37.7% | -14.9% | +38.6% | -48.2% | -14.2% | +338.5% | +47.2% | |
| – | +29,262.4% | -142.1% | – | – | – | +1,463.8% | +421.6% | -116.8% | – | – | +91.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.